APHINITY Update - Pertuzumab in HER2+ breast cancer

APHINITY Update - Pertuzumab in HER2+ breast cancer

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02Подробнее

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Meet the expert : Webinar 3 - Updates in Management Of Her2 Positive Breast CancerПодробнее

Meet the expert : Webinar 3 - Updates in Management Of Her2 Positive Breast Cancer

APHINITY Trial: Adjuvant HER2-Targeted Therapy in HER2+ BCПодробнее

APHINITY Trial: Adjuvant HER2-Targeted Therapy in HER2+ BC

Pertuzumab plus trastuzumab and chemotherapy continues to show benefit in HER2-positive breast c...Подробнее

Pertuzumab plus trastuzumab and chemotherapy continues to show benefit in HER2-positive breast c...

Актуальное